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Background: This research is carried out to determine impor-
tant risk factors in the development of Acinetobacter baumannii
infections in intensive care units by comparing infections due to
Escherichia coli infections at Military Medical Hospital between
2008-2011 years.
Patien’st age;pneumonia;comorbid disease like HIV; diabetes
mellitus; cardiovascular system; respiratuary system disease; can-
cer;high APACHE2 score; total parenteral nutrition existence;
hospitalisation period before and after culture; previous hospital-
isation existence; mechanic ventilation; central venous catheter;
carbapenem ﬂoroquinolon cephalosporins aminoglicoside resis-
tance and usage before culture; previous antibiotic usage are
investigated.
Controlling these risk factors and decresing the use of extended
antibiotics as carbapenems and cephalosporins; decreasing hos-
pitalisation in intensive care units and catheter usage besides
indication; seem to reduce due to Acinetobacter baumannii.
Methods & Materials: This is a prospective studyThere were
100patients infectedwithA.baumannii and100patientswithE.coli
hospitalised in intensive care units.
Risk factors are investigated and found out the potential of risk
factors; prevention of death and treatment policies.
Results: Age, respiratuary disease and cardiovascular system
disesase, diabetes mellitus, high APACHE 2 score, immunosupres-
sion,antibiotic usage hospitalisation before infection especially in
intensive casre units, central venous and nasogastric catheter,
mechanic ventilation are found as risk factors for A.baumannii
infections. Transfusion# hemodialysis and trauma are not found
as risk factors.
Sensitivity to ﬂoroquinolons 3.3%, cephalosporins 6.7%, car-
bapenems 26.7%, aminoglycosides 33,3%, tygecycline 73.3%,
colistine 100% is found.
Conclusion: Patients should not be hospitalised in intensive
care units if not needed and externalised as soon as possible.
Patients should be seperated from mechanic ventilators. catheters
espec’ally central cathter if not needed. Usage prior antibioticsmay
cause resistance; death; ineffectiveness. Therefore to increase ther-
apy effectiveness and to control nosocomial infections;hospital and
unit ﬂora, resistance to antibiotics, patient’s illness, prior antibiotic
usasge and hospitalisation time should be looked for.
Education should be given by infection control commitee, sur-
viance should be done. Antibiotic sensitivity can be investigated in
intensive care units.
http://dx.doi.org/10.1016/j.ijid.2014.03.1287
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Sustained reduction in ventilator-associated
pneumonia in a tertiary care hospital
A. Al Thaqaﬁ, M. Yaseen ∗, L. Medhat, A. Qudsi, A.
Zahrani, Y. Tashkandi
King Abdulaziz Medical City for National Guards,
Jeddah, Saudi Arabia
Background: Ventilator-associated pneumonia (VAP) is a lead-
ing cause of morbidity and mortality in intensive care units. Both
patients and treatment related risk factors contribute to the inci-
dence of ventilator-associated pneumonia. Hospital mortality of
ventilated patients who develop VAP is 46 percent compared to
32 percent for ventilated patients who do not develop VAP.
Methods & Materials: This study was conducted in King Abdu-
laziz Medical City Jeddah Saudi Arabia. A multidisciplinary team
was convened to work together and come up with prevention
strategies to reduce the rate of VAP in a 22 bedmedical and surgical
ICU. The Institute for Healthcare Improvement Ventilator Bundle
was instituted and included head-of-bed elevation (30-45 degree),
extubation assessment, sedation break, peptic ulcer prophylaxis,
and deep vein thrombosis prophylaxis. A daily checklist was con-
sidered compliant if all 5 items were performed for each patient.
The data was collected on a daily basis by the Infection Prevention-
ist and was analyzed and presented quarterly. The team meeting
was held regularly to discuss the cases of VAP and any issue related
to the compliance to the Ventilator Bundle.
Results: VAP rate at the timeof initializing theVentilator Bundle
was 13.5 cases/1000 ventilator days in the ﬁrst quarter of 2008 (8.4
overall in 2008) with 64% compliance to the Ventilator Bundle in
the ﬁrst quarter of 2008. Compliance with the Ventilator Bundle
increased to 97% and the rate of VAP decreased to 0.6 cases/1000
ventilator days in the last quarter of 2012. The reduction in VAP
rate and improvement in bundle compliance has been consistant
since 2008 until end of 2012.
Conclusion: Initiation of the VAP Bundle with sustained
improvement in compliance is associated with a signiﬁcantly
reduced incidence of VAP in ICU patients. Regular team meetings
to discuss the compliance issues and brainstorming appropriate
solutions resulted in a consistent improvement in the VAP rate.
http://dx.doi.org/10.1016/j.ijid.2014.03.1288
